Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD
Condition: ADHD Interventions: Drug: AMPH ER Tab 5, 10, 15 and 20 mg; Drug: AMPH ER Tab Matching Placebo 5, 10, 15 and 20 mg Sponsors: Tris Pharma, Inc.; Premier Research Group plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials